Novel first-line treatment option for mantle cell lymphoma

Presented By

Prof. Michael Wang, Anderson Cancer Center, TX, USA

Trial

Phase 3, SHINE

Conference

ASCO 2022

5 August, 2022 14:30

Novel anti-CD19 plus lenalidomide prolonged survival in R/R DLBCL

Expert

Dr Grzegorz Nowakowski, Mayo Clinic, Rochester, USA

Trial

Cohort study, RE-MIND2

Conference

ASH 2021

4 February, 2022 11:08

Expert

Dr Jennifer Woyach, Ohio State University, OH, USA

Trial

Phase 3, Alliance A041202

Conference

ASH 2021

3 February, 2022 23:22

Presented By

Prof. John Byrd, Ohio State University Comprehensive Cancer Centre, USA

Trial

Phase 2, ACE-CL-001, ASCEND

Conference

EHA 2020

9 September, 2020 12:19

Presented By

Dr Paolo Ghia, Vita-Salute San Raffaele University, Italy

Trial

Phase 3, ASCEND

Conference

EHA 2019

9 August, 2019 15:28